| Disease Specific Interactions between Host Protein and DME (HOSPPI) |
| ICD Disease Classification Healthy |
| ICD-11: Healthy |
Click to Show/Hide the Full List of HOSPPI: 3 HOSPPI
|
| Transcription-factor regulation |
| Early growth response 3 (EGR3) |
Health |
Activation |
| Uniprot ID |
|
| Interaction Name |
EGR3-CAT interaction |
[1] |
| Studied Cell Lines |
Rodent and human fibroblasts and a monkey kidney epithelial cell line |
| Ensembl ID |
|
| Description |
Early growth response 3 (EGR3) is reported to activate the transcription of CAT gene, which leads to an increased expression of the drug-metabolizing enzyme Catalase. As a result, the interaction between EGR3 and CAT can activate the drug-metabolizing process of Catalase. |
| PPA receptor delta (PPARD) |
Health |
Activation |
| Uniprot ID |
|
| Interaction Name |
PPARD-CAT interaction |
[3] |
| Studied Cell Lines |
Human umbilical vein endothelial cell line |
| Ensembl ID |
|
| Description |
PPA receptor delta (PPARD) is reported to activate the transcription of CAT gene, which leads to an increased expression of the drug-metabolizing enzyme Catalase. As a result, the interaction between PPARD and CAT can activate the drug-metabolizing process of Catalase. |
| Non-coding RNA regulation |
| hsa-miR-30b-5p |
Health |
Suppression |
| miRBase ID |
|
| Interaction Name |
hsa-miR-30b-5p--CAT regulation |
[2] |
| Studied Cell Lines |
ARPE-19 cell line |
| Description |
hsa-miR-30b-5p is reported to suppress CAT mRNA translation by binding to the 3' untranslated region (3'UTR) of CAT mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Catalase. |
| ICD Disease Classification 02 Neoplasms |
| ICD-11: 2C60 Breast cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
| Transcription-factor regulation |
| NFE2-related factor 2 (NFE2L2) |
Breast cancer |
Activation |
| Uniprot ID |
|
| Interaction Name |
NFE2L2-CAT interaction |
[4] |
| Studied Cell Lines |
MCF-7, T47D and HCC1937 cell lines |
| Ensembl ID |
|
| Description |
NFE2-related factor 2 (NFE2L2) is reported to activate the transcription of CAT gene, which leads to an increased expression of the drug-metabolizing enzyme Catalase. As a result, the interaction between NFE2L2 and CAT can activate the drug-metabolizing process of Catalase. |
|
|
|
|
|
|